Findings could point to new strategies to treat Alzheimer’s
Author: The SOURCE/Medicine & Health
Aging-related genomic culprit found in Alzheimer’s disease
With new technique, patient-derived neurons accurately model late-onset Alzheimer’s, point to potential treatments
Accuracy of diagnostic blood tests for Alzheimer’s disease varies
Head-to-head comparison of six tests reveals which ones could replace spinal taps, brain scans
Researchers find biological clues to mental health impacts of prenatal cannabis exposure
Scientists are trying to understand how cannabis may affect long-term neurodevelopment when people were exposed to it in the womb. Previous work by Washington University in St. Louis researchers Sarah Paul and David Baranger in the Behavioral Research and Imaging Neurogenetics (BRAIN) lab led by Ryan Bogdan, PhD, found associations between prenatal cannabis exposure and potential mental health conditions in childhood […]
Gut bacteria boost immune response to fight tumors
Roughly one in five cancer patients benefits from immunotherapy – a treatment that harnesses the immune system to fight cancer. Such an approach to beating cancer has seen significant success in lung cancer and melanoma, among others. Optimistic about its potential, researchers are exploring strategies to improve immunotherapy for cancers that don’t respond well to […]
International trials underway for childhood malnutrition therapy developed at WashU
Gift from Andy Newman supports world-changing research on the gut microbiome
Epilepsy drug prevents brain tumors in mice with NF1
Study lays groundwork for clinical trial aimed at preventing brain tumors in children with NF1
Award of up to $31 million supports development of osteoarthritis treatment
Researchers aim to create treatment that promotes tissue regeneration, restores joints
Neurons help flush waste out of brain during sleep
There lies a paradox in sleep. Its apparent tranquility juxtaposes with the brain’s bustling activity. The night is still, but the brain is far from dormant. During sleep, brain cells produce bursts of electrical pulses that cumulate into rhythmic waves — a sign of heightened brain cell function. But why is the brain active when we […]
Alzheimer’s blood test performs as well as FDA-approved spinal fluid tests
Could make early Alzheimer’s diagnosis, treatment accessible to more people
Clues to preventing Alzheimer’s come from patient who, despite genetics, evaded disease
Breaking link between early, late stages of disease may prevent dementia
Gut bacteria of malnourished children benefit from key elements in therapeutic food
Findings could guide recommendations for treating, preventing childhood malnutrition
Team to develop breathalyzer test for COVID, RSV, influenza A
Chakrabarty, Cirrito to develop test with $3.6 million grant from Flu Lab
How do toxic proteins accumulate in Alzheimer’s and other diseases?
Key steps leading to such accumulation identified; could inform new therapeutic approaches
What to know about the new Alzheimer’s drug Leqembi
Washington University involved in clinical trials, will offer drug in collaboration with BJC HealthCare
Diagnosis of rare, genetic muscle disease improved by new approach
Accurate diagnosis is a crucial step toward appropriate treatment
Stress increases Alzheimer’s risk in female mice but not males
Alzheimer’s proteins rise sharply in response to stress in female mice
Mind-body connection is built into brain, study suggests
Findings point to brain areas that integrate planning, purpose, physiology, behavior, movement
Discovery of T cells’ role in Alzheimer’s, related diseases, suggests new treatment strategy
Findings, in mice, open up drug development possibilities for brain diseases linked to tau protein
Adding med to antidepressant may help older adults with treatment-resistant depression
For older adults with clinical depression that has not responded to standard treatments, adding the drug aripiprazole (brand name Abilify) to an antidepressant they’re already taking is more effective than switching from one antidepressant to another, according to a new multicenter study led by Washington University School of Medicine in St. Louis. Aripiprazole originally was […]
Disrupted flow of brain fluid may underlie neurodevelopmental disorders
New imaging technique reveals circulation patterns in developing brain
Gut bacteria affect brain health, mouse study shows
Findings suggest new approach to treating Alzheimer’s, other neurodegenerative diseases
WashU, Eisai form drug discovery collaboration
Focus is on therapies for Alzheimer’s, other neurodegenerative diseases
Immunotherapy eliminates disease-causing cells in mice with MS-like disease
Successful cancer treatment approach extended to autoimmune disease
Study yields clues to why Alzheimer’s disease damages certain parts of the brain
Findings could help explain rare symptoms such as problems with language, vision
Rejuvenated immune cells can improve clearance of toxic waste from brain
Findings in mice suggest new therapeutic approach to Alzheimer’s, other age-related diseases
Cellular housekeeping process implicated in fatal neurological disorder
Neurons made from Huntington’s disease patients’ skin cells shed light on cognitive decline
New strategy shows potential to block nerve loss in neurodegenerative diseases
Research into how key molecule triggers axon death may lead to new therapies
Scientists ID pathway that triggers mice to scratch when they see others do the same
Behavior surprisingly does not require brain’s visual cortex
Investigational drug for genetic form of ALS improves disease’s molecular signs
Extended use of tofersen may help stabilize muscle strength, control
New center’s aim: To ID biomarkers of neurodegenerative diseases
A new center established at Washington University School of Medicine in St. Louis aims to accelerate research into biomarkers of neurodegenerative conditions such as Huntington’s and Parkinson’s diseases, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and the so-called tauopathies, a group that includes Alzheimer’s disease along with rarer diseases such as frontotemporal dementia, corticobasal syndrome […]
Protein linked to intellectual disability has complex role
Finding therapies for fragile X may depend on understanding the many ways protein’s loss affects brain
Diabetes, metabolic syndrome in mice treated with novel class of compounds
Improves insulin secretion, lowers blood sugar
Emotional aspects of chronic pain isolated in brain circuitry
Animal study could help ID new treatment targets for negative emotions linked to pain
‘Fight or flight’ – unless internal clocks are disrupted, study in mice shows
For humans and animals, many aspects of normal behavior and physiology rely on the proper functioning of the body’s circadian clocks.
Cannabis use disorder: another COVID risk factor
Research indicates problematic marijuana use is correlated with poorer COVID-19 outcomes
New Alzheimer’s treatment targets identified
Study points to FDA-approved drugs that have potential to slow or reverse brain damage
New snack foods nurture healthy gut microbiome
Microbiome-modifying foods designed with specific combinations of plant fibers
WashU, Pitt awarded $10.7 million for Alzheimer’s disease research
Study to look for genetic pathways that lead to formation of plaques, tangles
For malnourished children, a new type of microbiome-directed food boosts growth
New food is designed to nurture healthy gut microbes
Chemo for glioblastoma may work better in morning than evening
Study indicates timing of chemotherapy could improve treatment for deadly brain cancer
Zika virus helps destroy deadly brain cancer in mice
Virus-based therapy may unlock potential of immunotherapy for glioblastoma
Brain rewires itself after injury ‘on the edge of what’s compatible with life’
Stroke suffered as newborn went undetected for 13 years
International Alzheimer’s clinical trial to test tau drugs
Antibody is first of three tau drugs to be evaluated